Johnson & Johnson Q1 Profit Exceeds Expectations
📊 JNJ — Piyasa Yorumu
▲ up · 60%Johnson & Johnson (JNJ) reported better-than-expected first-quarter earnings, providing a positive catalyst. However, technical indicators paint a weak picture: the RSI at 36 is nearing oversold territory, the MACD is below its signal line, and the stock is trading below both its 20-day and 50-day moving averages. While a short-term recovery driven by the positive news is possible, upside is likely limited due to technical resistance and a prevailing downtrend. Therefore, although the directional bias is upward, conviction remains moderate.
📊 ABBV — Piyasa Yorumu
■ neutral · 60%Although ABBV stock has risen nearly 2% in the last 24 hours, its RSI of 57 indicates it is neither overbought nor oversold. The MACD remains below the signal line, suggesting weak short-term momentum. The price is trading just below the 20-day moving average, pointing to potential resistance. Since the news headline pertains to JNJ, no direct impact on ABBV is expected. Therefore, short-term direction remains uncertain.
📊 BMY — Piyasa Yorumu
■ neutral · 60%BMY stock could receive a sectoral tailwind from Johnson & Johnson's positive quarterly results, but the impact may remain limited. Technical indicators present a weak outlook: RSI at 39 is in the sell zone, MACD is below the signal line, and the price is below both the 20-day and 50-day moving averages. The 1% decline in the last close also confirms negative short-term momentum. Therefore, despite the positive news effect, the direction is assessed as neutral due to the weight of the technical picture.
📊 PFE — Piyasa Yorumu
■ neutral · 30%The news headline belongs to Johnson & Johnson and does not directly affect PFE, but the positive sentiment in the sector may have a limited short-term reflection. Technical indicators paint a weak picture: RSI at 42 is near the oversold zone, MACD is below the signal line, and the price is trading below SMA20 and SMA50. The last closing price was $26.32, slightly below the 20-day moving average ($26.48), indicating low short-term momentum. Despite a slight 0.2% rise in the last 24 hours, the overall technical structure does not signal a recovery. Therefore, the impact of the news remains limited, and the price is expected to trade sideways at current levels.